Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor
Year: 2009
Type: article
Source: Clinical Immunology
Institution: Abbott (United States)
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Abbott Laboratories
OpenAlex ID: W2009735641
